Cargando…

Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality

BACKGROUND AND AIMS: Associations between soy intake and risk of cancer have been evaluated in prospective observational studies with inconsistent results. Whether the potential anticancer effects offered by soy were attributed to soy isoflavones and soy protein still needs to be elucidated. This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yahui, Wang, Mingxu, Li, Zhaofang, Jiang, Hong, Shi, Jia, Shi, Xin, Liu, Sijiao, Zhao, Jinping, Kong, Liyun, Zhang, Wei, Ma, Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931954/
https://www.ncbi.nlm.nih.gov/pubmed/35308286
http://dx.doi.org/10.3389/fnut.2022.847421
_version_ 1784671355482931200
author Fan, Yahui
Wang, Mingxu
Li, Zhaofang
Jiang, Hong
Shi, Jia
Shi, Xin
Liu, Sijiao
Zhao, Jinping
Kong, Liyun
Zhang, Wei
Ma, Le
author_facet Fan, Yahui
Wang, Mingxu
Li, Zhaofang
Jiang, Hong
Shi, Jia
Shi, Xin
Liu, Sijiao
Zhao, Jinping
Kong, Liyun
Zhang, Wei
Ma, Le
author_sort Fan, Yahui
collection PubMed
description BACKGROUND AND AIMS: Associations between soy intake and risk of cancer have been evaluated in prospective observational studies with inconsistent results. Whether the potential anticancer effects offered by soy were attributed to soy isoflavones and soy protein still needs to be elucidated. This study aimed to comprehensively quantify the association of soy, soy isoflavones and soy protein intake with risk of cancer incidence and cancer mortality by conducting a meta-analysis of all available studies. METHODS: PubMed, Embase, Web of Science, and Cochrane Library databases were searched up to 16 September 2021. Prospective cohort studies that examined the effect of soy, soy isoflavones and soy protein on cancer incidence and cancer mortality were identified. Random-effects models were used to pool the multivariable-adjusted relative risks (RRs) and corresponding 95% confidence intervals (CIs). The potential dose-response relations were explored by using generalized least-squares trend estimation. RESULTS: Eighty one prospective cohort studies were included in the meta-analysis. A higher intake of soy was significantly associated with a 10% reduced risk of cancer incidence (RR, 0.90; 95% CI, 0.83–0.96). Each additional 25 g/d soy intake decreased the risk of cancer incidence by 4%. Intake of soy isoflavones was inversely associated with risk of cancer incidence (RR, 0.94; 95% CI, 0.89–0.99), whereas no significant association was observed for soy protein. The risk of cancer incidence was reduced by 4% with each 10 mg/d increment of soy isoflavones intake. Similar inverse associations were also found for soy in relation to site-specific cancers, particularly lung cancer (RR, 0.67; 95%CI, 0.52–0.86) and prostate cancer (RR, 0.88; 95%CI, 0.78–0.99). However, high intake of soy, soy isoflavones and soy protein were not associated with cancer mortality. CONCLUSIONS: Higher intake of soy and soy isoflavones were inversely associated with risk of cancer incidence, which suggested that the beneficial role of soy against cancer might be primarily attributed to soy isoflavones. These findings support recommendations to include soy as part of a healthy dietary pattern for the prevention of cancer.
format Online
Article
Text
id pubmed-8931954
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89319542022-03-19 Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality Fan, Yahui Wang, Mingxu Li, Zhaofang Jiang, Hong Shi, Jia Shi, Xin Liu, Sijiao Zhao, Jinping Kong, Liyun Zhang, Wei Ma, Le Front Nutr Nutrition BACKGROUND AND AIMS: Associations between soy intake and risk of cancer have been evaluated in prospective observational studies with inconsistent results. Whether the potential anticancer effects offered by soy were attributed to soy isoflavones and soy protein still needs to be elucidated. This study aimed to comprehensively quantify the association of soy, soy isoflavones and soy protein intake with risk of cancer incidence and cancer mortality by conducting a meta-analysis of all available studies. METHODS: PubMed, Embase, Web of Science, and Cochrane Library databases were searched up to 16 September 2021. Prospective cohort studies that examined the effect of soy, soy isoflavones and soy protein on cancer incidence and cancer mortality were identified. Random-effects models were used to pool the multivariable-adjusted relative risks (RRs) and corresponding 95% confidence intervals (CIs). The potential dose-response relations were explored by using generalized least-squares trend estimation. RESULTS: Eighty one prospective cohort studies were included in the meta-analysis. A higher intake of soy was significantly associated with a 10% reduced risk of cancer incidence (RR, 0.90; 95% CI, 0.83–0.96). Each additional 25 g/d soy intake decreased the risk of cancer incidence by 4%. Intake of soy isoflavones was inversely associated with risk of cancer incidence (RR, 0.94; 95% CI, 0.89–0.99), whereas no significant association was observed for soy protein. The risk of cancer incidence was reduced by 4% with each 10 mg/d increment of soy isoflavones intake. Similar inverse associations were also found for soy in relation to site-specific cancers, particularly lung cancer (RR, 0.67; 95%CI, 0.52–0.86) and prostate cancer (RR, 0.88; 95%CI, 0.78–0.99). However, high intake of soy, soy isoflavones and soy protein were not associated with cancer mortality. CONCLUSIONS: Higher intake of soy and soy isoflavones were inversely associated with risk of cancer incidence, which suggested that the beneficial role of soy against cancer might be primarily attributed to soy isoflavones. These findings support recommendations to include soy as part of a healthy dietary pattern for the prevention of cancer. Frontiers Media S.A. 2022-03-04 /pmc/articles/PMC8931954/ /pubmed/35308286 http://dx.doi.org/10.3389/fnut.2022.847421 Text en Copyright © 2022 Fan, Wang, Li, Jiang, Shi, Shi, Liu, Zhao, Kong, Zhang and Ma. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nutrition
Fan, Yahui
Wang, Mingxu
Li, Zhaofang
Jiang, Hong
Shi, Jia
Shi, Xin
Liu, Sijiao
Zhao, Jinping
Kong, Liyun
Zhang, Wei
Ma, Le
Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality
title Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality
title_full Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality
title_fullStr Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality
title_full_unstemmed Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality
title_short Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality
title_sort intake of soy, soy isoflavones and soy protein and risk of cancer incidence and mortality
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931954/
https://www.ncbi.nlm.nih.gov/pubmed/35308286
http://dx.doi.org/10.3389/fnut.2022.847421
work_keys_str_mv AT fanyahui intakeofsoysoyisoflavonesandsoyproteinandriskofcancerincidenceandmortality
AT wangmingxu intakeofsoysoyisoflavonesandsoyproteinandriskofcancerincidenceandmortality
AT lizhaofang intakeofsoysoyisoflavonesandsoyproteinandriskofcancerincidenceandmortality
AT jianghong intakeofsoysoyisoflavonesandsoyproteinandriskofcancerincidenceandmortality
AT shijia intakeofsoysoyisoflavonesandsoyproteinandriskofcancerincidenceandmortality
AT shixin intakeofsoysoyisoflavonesandsoyproteinandriskofcancerincidenceandmortality
AT liusijiao intakeofsoysoyisoflavonesandsoyproteinandriskofcancerincidenceandmortality
AT zhaojinping intakeofsoysoyisoflavonesandsoyproteinandriskofcancerincidenceandmortality
AT kongliyun intakeofsoysoyisoflavonesandsoyproteinandriskofcancerincidenceandmortality
AT zhangwei intakeofsoysoyisoflavonesandsoyproteinandriskofcancerincidenceandmortality
AT male intakeofsoysoyisoflavonesandsoyproteinandriskofcancerincidenceandmortality